Overview
The investigators plan to collect clinical and molecular data, including ICH, PCR, NGS and methylome, from patients operated on for grade 2 or grade 3 meningioma. The purpose of the study is to identify reliable and easy-to-assess predictive factors for recurrence and survival after surgery.
Eligibility
Inclusion Criteria:
- Patient operated for atypical (grade 2) meningioma; or
- Patient operated for anaplastic (grade 3) meningioma;
- Timeframe for surgery, 1999-2019
Exclusion criteria
- Patient lost at follow-up